KSR1 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with KSR1 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with KSR1 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with KSR1 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with KSR1 Up.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000138271 - G protein-coupled receptor 87

Gene

ENSG00000125779 - pantothenate kinase 2

Gene

ENSG00000123843 - complement component 4 binding protein beta

Gene

ENSG00000141574 - secreted and transmembrane 1

Gene

ENSG00000109072 - vitronectin

Gene

ENSG00000158104 - 4-hydroxyphenylpyruvate dioxygenase

Gene

ENSG00000198171 - DDRGK domain containing 1

Gene

ENSG00000196504 - pre-mRNA processing factor 40A

Gene

ENSG00000092978 - G-patch domain containing 2

  • Gene

    ENSG00000138271 - G protein-coupled receptor 87


  • Gene

    ENSG00000125779 - pantothenate kinase 2


  • Gene

    ENSG00000123843 - complement component 4 binding protein beta


  • Gene

    ENSG00000141574 - secreted and transmembrane 1


  • Gene

    ENSG00000109072 - vitronectin


  • Gene

    ENSG00000158104 - 4-hydroxyphenylpyruvate dioxygenase


  • Gene

    ENSG00000198171 - DDRGK domain containing 1


  • Gene

    ENSG00000196504 - pre-mRNA processing factor 40A


  • Gene

    ENSG00000092978 - G-patch domain containing 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.